298 related articles for article (PubMed ID: 6352137)
1. Influence of food intake on presystemic clearance of drugs.
Melander A; McLean A
Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137
[TBL] [Abstract][Full Text] [Related]
2. Influence of food on the bioavailability of drugs.
Melander A
Clin Pharmacokinet; 1978; 3(5):337-51. PubMed ID: 81118
[TBL] [Abstract][Full Text] [Related]
3. Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.
Byrne AJ; McNeil JJ; Harrison PM; Louis W; Tonkin AM; McLean AJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):45S-50S. PubMed ID: 6743474
[TBL] [Abstract][Full Text] [Related]
4. Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation.
Liedholm H; Melander A
Clin Pharmacol Ther; 1986 Jul; 40(1):29-36. PubMed ID: 3720177
[TBL] [Abstract][Full Text] [Related]
5. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
Zhang Z; Gao F; Jiang S; Ma L; Li Y
Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
[TBL] [Abstract][Full Text] [Related]
6. First-pass elimination. Basic concepts and clinical consequences.
Pond SM; Tozer TN
Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dixyrazine: low bioavailability, improved by food intake.
Liedholm H; Lidén A; Kroon L; Melander A; Wåhlin-Boll E
Drug Nutr Interact; 1985; 3(2):87-92. PubMed ID: 3987521
[TBL] [Abstract][Full Text] [Related]
8. Presystemic extraction: mechanisms and consequences.
Greenblatt DJ
J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
[TBL] [Abstract][Full Text] [Related]
9. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
10. Interaction between oral propranolol and hydralazine.
McLean AJ; Skews H; Bobik A; Dudley FJ
Clin Pharmacol Ther; 1980 Jun; 27(6):726-32. PubMed ID: 7379440
[TBL] [Abstract][Full Text] [Related]
11. Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.
Park BK
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):3S-10S. PubMed ID: 6146338
[TBL] [Abstract][Full Text] [Related]
12. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
[TBL] [Abstract][Full Text] [Related]
13. Influence of food on the bioavailability of "real" and "apparent" hydralazine from conventional and slow-release preparations.
Liedholm H; Wåhlin-Boll E; Hanson A; Melander A
Drug Nutr Interact; 1982; 1(4):293-302. PubMed ID: 6926836
[TBL] [Abstract][Full Text] [Related]
14. Food intake and the presystemic metabolism of single doses of amitriptyline and nortriptyline.
Liedholm H; Lidén A
Fundam Clin Pharmacol; 1998; 12(6):636-42. PubMed ID: 9818297
[TBL] [Abstract][Full Text] [Related]
15. Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
Bernkop-Schnürch A; Schmitz T
Curr Drug Metab; 2007 Jun; 8(5):509-17. PubMed ID: 17584022
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.
Patel JP; Brocks DR
Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1385-98. PubMed ID: 19663632
[TBL] [Abstract][Full Text] [Related]
17. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
[TBL] [Abstract][Full Text] [Related]
18. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans.
Wilkinson GR
Adv Drug Deliv Rev; 1997 Sep; 27(2-3):129-159. PubMed ID: 10837555
[TBL] [Abstract][Full Text] [Related]
19. Interactions affecting drug absorption.
Welling PG
Clin Pharmacokinet; 1984; 9(5):404-34. PubMed ID: 6388952
[TBL] [Abstract][Full Text] [Related]
20. Influence of food intake on the bioavailability of zuclopenthixol.
Aaes-Jørgensen T; Liedholm H; Melander A
Drug Nutr Interact; 1987; 5(3):157-60. PubMed ID: 3691322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
